PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 88861008 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 117 |
MARK SECTION | |
MARK | TARPEYO (see, http://uspto.report/TM/88861008/mark.png) |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | TARPEYO |
OWNER SECTION (current) | |
NAME | Calliditas Therapeutics AB |
MAILING ADDRESS | PO Box 70351 |
CITY | Stockholm |
ZIP/POSTAL CODE | SE-10724 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Sweden |
XXXX | |
OWNER SECTION (proposed) | |
NAME | Calliditas Therapeutics AB |
MAILING ADDRESS | PO Box 70351 |
CITY | Stockholm |
ZIP/POSTAL CODE | SE-10724 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Sweden |
XXXX | |
CORRESPONDENCE INFORMATION (current) | |
NAME | PAM KOHLI JACOBSON |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | Pam.Jacobson@klgates.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | SETrademarks@klgates.com; Grace.Carlson@klgates.com; Terri.Li.SE@klgates.com; SynchTeam@klgates.com |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | Pam Kohli Jacobson |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | Pam.Jacobson@klgates.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | SETrademarks@klgates.com; Grace.Carlson@klgates.com; Terri.Li.SE@klgates.com; SynchTeam@klgates.com |
DOCKET/REFERENCE NUMBER | 140314700023 |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 005 |
CURRENT IDENTIFICATION | Medical and pharmaceutical preparations for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases; Diagnostic preparations and materials in the nature of companion diagnostics kits comprising tubes, microtiterplates, diluents, vials, kit instructions, pipetting tools and devices, containers, packaging materials and reagents, kits comprising tubes, microtiterplates, diluents, vials, kit instructions, pipetting tools and devices, containers, packaging materials and reagents for diagnosis and prognosis for medical purposes; Pharmaceutical and natural remedy preparations for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases; Pharmaceutical drugs for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases; Pharmaceutical preparations for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases |
GOODS OR SERVICES | KEEP ALL LISTED |
EXTENSION SECTION | |
EXTENSION NUMBER | 1 |
ALLOWANCE MAIL DATE | 10/06/2020 |
STATEMENT OF USE | NO |
PAYMENT SECTION | |
NUMBER OF CLASSES | 1 |
SUBTOTAL AMOUNT [EXTENSION FEE] | 125 |
TOTAL AMOUNT | 125 |
SIGNATURE SECTION | |
SIGNATURE | /Pam Kohli Jacobson/ |
SIGNATORY'S NAME | Pam Kohli Jacobson |
SIGNATORY'S POSITION | Attorney of record, Washington bar member |
DATE SIGNED | 03/05/2021 |
SIGNATORY'S PHONE NUMBER | 206.370.7605 |
SIGNATURE METHOD | Sent to third party for signature |
FILING INFORMATION | |
SUBMIT DATE | Fri Mar 05 13:44:16 ET 2021 |
TEAS STAMP | USPTO/ESU-XXX.XXX.XX.X-20 210305134416671444-888610 08-770f38b6552d45f8a18c36 e4ebbfc5188646de56c414439 a29975212aa120e5cc5-DA-44 151503-202103051143151521 27 |
PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |